Odds of mortality or discharge to hospice reduced for those receiving supplemental oxygen or mechanical ventilation and/or ECMO
Your search for supplemental oxygen returned 13 results
Current evidence indicates that a 6mg dose of dexamethasone daily is effective for improving COVID-19 outcomes among patients receiving supplemental oxygen.
No significant difference versus placebo observed for hospitalized patients with COVID-19 receiving noninvasive supplemental oxygen
Annual respiratory syncytial virus-associated hospitalization rates varied from 35.7 to 132.3 per 1000 children aged younger than 6 months.
Gohibic is supplied as a 200mg/20mL solution in a single-dose vial for IV infusion after dilution.
Researchers examined the epidemiology and clinical outcomes of sporadic health care-associated respiratory syncytial virus infection in children.
InflaRx is working to increase supply of the product in the US as quickly as possible.
Significant reductions seen in RSV-related infections, RSV-related hospitalizations for three monoclonal antibodies versus placebo
The studies evaluated routine clinical practice data from more than 800 hospitals in the US.
Investigators developed and validated a machine learning tool providing an early indication of disease progression in community-acquired pneumonia.